Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Attralus Inc.
Headquarters: South San Francisco, CA, United States of America
Website: https://www.attralus.com/
Year Founded: 2019
Status: Private
BioCentury | Feb 9, 2024
Finance
Venture report: Scion’s launch, rounds for Neurona, Attralus and Basking
New firm, affiliated with NYC-based Petrichor, will put $310M fund toward company creation
BioCentury | Sep 10, 2022
Discovery & Translation
A suite of liquid biopsy approaches for cancer detection and more
BioCentury’s roundup of translational news
BioCentury | Sep 9, 2021
Deals
Sept. 8 Quick Takes: Logos leads crossovers in Attralus’ $116M round
Denner, Bauer join board of pan-amyloid removal company, plus: Resilience-Moderna, Exscientia-Gates
BioCentury | Aug 4, 2021
Management Tracks
Arbuckle becomes COO at Vertex
Plus: GlycoMimetics names Semerjian as King’s successor, plus updates from Pieris, Assembly and more
BioCentury | Jul 13, 2021
Product Development
The ATTR pipeline: Data Byte
Competition continues to heat up in the rare disease transthyretin amyloidosis (ATTR), with at least a dozen preclinical and clinical programs coming up behind the three marketed agents, according to
BioCentury | Jun 4, 2021
Finance
For $550M fourth fund, venBio adds firepower for later rounds
venBio’s fourth fund will target 12-15 investments and provide flexibility to maintain stakes in crossover rounds
BioCentury | May 10, 2021
Management Tracks
Atlas hires Truex as venture partner; plus SpringWorks, Codiak, Centessa, Attralus, LogicBio, uniQure, Atara, CymaBay and more
Samantha Truex joined Atlas Venture as its first female venture partner. Truex’s history with the VC includes roles in its portfolio companies, most recently as CEO at Quench Bio. She was
BioCentury | Sep 15, 2020
Emerging Company Profile
Attralus debuts with $25M series A to tackle systemic amyloidosis
Attralus looks to obtain clinical POC for first pan-amyloid therapy
Items per page:
1 - 8 of 8